SEC 13F Intelligence

Altium Capital Management LLC / CNST

Altium Capital Management LLC’s Constellation Pharmceticls I Position

Does Altium Capital Management LLC own Constellation Pharmceticls I (CNST)? Not currently — the last reported position was 158.7K shares worth $4M in Q1 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q1 2021
Shares
158.7K
% of Portfolio
+1.03%
Quarters Held
2
position exited

Position History CNST

Reported value by quarter
Q4 ’20: $4MQ4 ’20Q1 ’21: $4MQ1 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2021158.7K$4M+1.03%
Q4 2020134.2K$4M+1.44%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of CNST.